The AUC of the AFP/AFU combination was better than any other single biomarker (only AFP or AFU) of all-stage (Figure 6A and 6B) and early-stage (Figure 6C and 6D) hepatitis-related HCC in the test and validation groups. This evidence concerns the gene AFP and hepatocellular carcinoma.